ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Hetero-Functionalization of Carbon Nanotubes Termini with Single-Molecule Control.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hetero-Functionalization of Carbon Nanotubes Termini with Single-Molecule Control.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A strategy is presented for the asymmetric chemical functionalization of individual single-walled carbon nanotubes (SWCNTs) termini and their selective conjugation to distinct single moieties, i.e., the formation of bi-functionalized R-CNT-R' heterostructures. This study demonstrates this via the selective covalent attachment of metal nanoparticles (NPs) and semiconductor nanocrystals (quantum dots, QDs) at opposite ends of individual SWCNTs; the electronic coupling is further characterized between the distinct components of the hybrids. The general applicability of the methodology developed by this study can be beneficial for the design and development of novel SWCNT-based nanohybrid materials with single-molecule control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.